Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte Function

NCT03644771 is registered in ClinicalTrials.gov with Greater Boston Medical Associates as lead sponsor.

NCT NCT03644771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03644771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte Function
Lead sponsor
Greater Boston Medical Associates
Phase
Observational
Overall status
Unknown status
Start date
January 25, 2017
Completion date
December 31, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decrease of proteinuria with h.p. acthar gel and its effects on clinical and podocyte function